Aktis Oncology, Inc.
AKTS
$20.34
$1.226.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 81.21% | -23.68% | |||
| Total Receivables | -- | 0.00% | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -- | -6.27% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | -- | -23.45% | |||
|
|
|||||
| Total Current Assets | -- | -23.45% | |||
| Net Property, Plant & Equipment | -- | 30.54% | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | 64.44% | |||
| Total Assets | -- | -18.79% | |||
|
|
|||||
| Total Accounts Payable | -- | -9.44% | |||
| Total Accrued Expenses | -- | 50.40% | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | 1.47% | |||
| Total Finance Division Other Current Liabilities | -- | 101.16% | |||
| Total Other Current Liabilities | -- | 101.16% | |||
| Total Current Liabilities | -- | 65.95% | |||
|
|
|||||
| Total Current Liabilities | -- | 65.95% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | -4.49% | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -29.16% | |||
| Total Liabilities | -- | -3.66% | |||
|
|
|||||
| Common Stock & APIC | -- | 111.43% | |||
| Retained Earnings | -- | -68.65% | |||
| Treasury Stock & Other | -- | -66.13% | |||
| Total Common Equity | 676.41% | -66.45% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | 0.00% | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | 0.00% | |||
|
|
|||||
| Total Common Equity | 676.41% | -66.45% | |||
| Total Preferred Equity | -- | 0.00% | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 106.06% | -23.76% | |||
|
|
|||||